Vivus, Inc. Opens Sharply Higher On ED Drug Marketing Approval

By: via Benzinga
Vivus Inc. (NASDAQ: VVUS) shares rose sharply in pre-market activity after its fast-acting erectile dysfunction drug won marketing ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.